About the Foundation

The Foundation for Cancer Research Support (RakFond) is a non-profit organization whose main tasks include: financing research and development activities, development of new methods and tools for the prevention, diagnosis and treatment of cancer, promoting the development and improvement of research and scientific activities of research institutions, scientific centers, oncological hospitals, and individual specialists in the field of oncology. The Foundation was founded in 2017 and operates on the territory of the Russian Federation.

NEWS

VIEW ALL

20 Sep

RESULTS OF THE COMPETITION OF CLINICAL RESEARCH PROJECTS IN ONCOLOGY

The review of the applications for the competition of clinical research projects in oncology of the Foundation for Cancer Research Support (RFP 2019-01) has been completed... Detailed information on the winners and their projects is posted in the Supported Research section... more

25 Aug

RAKFOND NOMINATED FOR THE "HEADLINER OF THE YEAR" PRIZE

RakFond will participate in the competition for the "Headliner of the Year" National Prize in the "Science and Education" category. Voting will be open between October 16 and December 15, 2019. Please support us! more

New interview with Kristina Zakurdaeva about the prospects of cancer control on "Russia 24" TV channel

The interviewee is a hematologist and the Founder of RakFond Kristina Zakurdaeva, MD, PhD. The interview is in Russian, with no translation available... more

14 Aug

HOW FRAGILE ARE THE CLINICAL TRIALS SUPPORTING APPROVAL OF NOVEL ANTICANCER MEDICINES

A new article, recently published in The Lancet Oncology, raises a question of the fragility of phase 3, randomized, controlled trials supporting anticancer drugs that were approved by the FDA... more

2 Jul

SUBMISSION OF APPLICATIONS FOR THE CLINICAL RESEARCH PROJECTS COMPETITION IS CLOSED

Ten full applications were received in response to the Request For Proposals for the RakFond's competition of clinical research projects in oncology... more

13 Jun

One week left to register applications for the competition of clinical research projects in oncology

Applications submission is open for proposals of randomized clinical trials in oncology and related areas. Application due date is July 01, 2019. Online pre-registration is required by June 20, 2019... more

Articles and Reviews

View All

PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING

Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA... more

WHAT IS CLINICAL RESEARCH

RakFond's SAB Member Professor Nikolay Zhukov, MD, DSci, explains in this video what clinical research is, he describes different types of clinical studies, what they provide to medical doctors, and why taking part in clinical trials is important for patients... more

18 Jun

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II

Compiled by Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting... more

14 Jun

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I

The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting... more

15 Feb

American Society of Clinical Oncology (ASCO) Issues the 14th Annual Report on Progress Against Cancer

ASCO’s Clinical Cancer Advances 2019 highlights the most significant clinical research advances of the past year and identifies priority areas where research efforts should be focused to accelerate progress against cancer... more

28 Dec

2018 RESEARCH YEAR: ONCOLOGY NEWS

The area of oncology in 2018 was full of events and news, new studies results, some of them were practice-changing. Here we publish selected interesting news of this year... more

Interviews with experts

RakFond's experts talk in their short interviews about their choice to become an oncologist, which cancer research they could name as their favorite, and why cancer research support is important.

Interview with Tatiana Semiglazova

Interview with Tatiana Semiglazova, MD, DSci, Professor, Head of Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N.N. Petrov National Medical Research Center of Oncology (St. Petersburg, Russia), Professor at the Department of Oncology, I.I. Mechnikov North-Western State Medical University (St. Petersburg, Russia)...The topic of the interview is the rehabilitation of cancer patients... more

Interview with Andrei Gudkov

Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond's Scientific Advisory Board... Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us... more

Interview with Katerina Gurova

Interview with Katerina Gurova, M.D., Ph.D., Professor of Oncology, Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA)... Learn about the regulation of reading in the library of genes, the role of the "gene of conscience"... more

Interview with Jacek Gronwald

Interview with Jacek Gronwald, PhD, Professor, Department of Genetics and Pathology, Pomeranian Medical University (Szczecin, Poland), Member of RakFond's Scientific Advisory Board. Learn about hereditary cancers, studies of lifestyle factors in oncology... more

Interview with Alexey Danilov

Interview with Alexey Danilov, Associate Professor of Medicine, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (Portland, USA), Member of RakFond's Scientific Advisory Board...Learn about research translation from bench to bedside, the discovery and research of the novel therapies in hematologic malignancies... more

Interview with Alexey Tryakin

Interview with Alexey Tryakin, M.D., D.Sci., Chief Scientist, Department of Clinical Pharmacology and Chemotherapy of N.N. Blokhin National Medical Research Center of Oncology (Moscow, Russia)... Learn about the inception of the targeted therapy in oncology, what advantages of participating in clinical trials bring to doctors and patients... more

About the Foundation

NEWS

Articles and Reviews

Interviews with experts

Our Supporters